Search
Now showing items 1-2 of 2
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
(BioMed Central, 2015)
Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations and their ...
Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya
(BioMed Central, 2015)
Information about HBV sero-markers, infection stages and genotypes in HIV-1 infected and uninfected
injection and non-injection drug users (IDUs) in Kenya remains elusive.